实验概要
Quantitative PCR involves co-amplification of two templates: a constant amount of a preparation containing the desired target sequence and varying amounts of a reference template. After amplification, the concentration of the target sequence in the preparation of nucleic acid under test is established by interpolation into a standard curve. Quantitation of nucleic acids by PCR is best performed by real-time PCR. However, the following robust protocol, which uses radioactivity to quantify PCRproducts, remains useful when a real-time instrument is unavailable. The method can be easily adapted to other methods of quantification such as fluorometry.
主要试剂
| Reagents and Solutions |
|
| Enzymes and Buffers |
|
| Nucleic Acids/Oligonucleotides |
|
| Radiolabeled Compounds |
|
| Gels/Loading Buffers |
|
| Additional Items |
|
实验步骤
1.
Design and prepare a reference template suitable for the task at hand.
Measure the concentration of the reference template as carefully as
possible, preferably by fluorometry. Alternatively, estimate the amount
of reference template after gel electrophoresis and ethidium bromide
staining.
2. Make a series of tenfold dilutions (in H2O) containing concentrations of the reference template ranging from 10-6 to 10-12 M. After using the dilutions (Step 3), they should be stored at -70°C for later use in Step 8.
3.
If starting from RNA, denature the target RNA by incubating aliquots
for 5 minutes at 75°C, followed by rapid chilling in ice water. Then,
without delay, set up a series of reverse transcription reactions
containing increasing amounts of reference template in sterile 0.5-ml
microfuge tubes. For each reaction in the series, prepare the following:
| 10x amplification buffer | 2 µl |
| 20 mM solution of four dNTPs (pH 8.0) | 1 µl |
| 20 µM antisense primer | 2.5 µl |
| approximately 20 units/ µl placental RNase inhibitor | 1 µl |
| 50 mM MgCl2 | 1 µl |
| denatured target RNA | 10 pg to 1.0 µg |
| 100-200 units/ µl reverse transcriptase | 1 µl |
| tenfold dilution of reference template | 1 µl |
| H2O | to 20 µl |
Incubate the reaction for 60 minutes at 37°C and then denature the reverse transcriptase by heating to 95°C for 20 minutes.
4.
In sterile 0.5-ml microfuge tubes, amplification tubes, or the wells of
a sterile microtiter plate, set up amplification reactions with each
reaction in the series from Step 3:
| reverse transcriptase reaction (Step 3) or target DNA | 1 µl |
| 20 µlM sense primer | 1.5 µl |
| 20 µlM antisense primer | 1.25 µl |
| 10x amplification buffer | 5 µl |
| [α-32P]dCTP (3000 Ci/mmole) | 10 µCi |
| 20 mM solution of four dNTPs | 1 µl |
| thermostable DNA polymerase | 2 units |
| H2O | to 50 µl |
注意事项
1.
Do not reduce the concentration of unlabeled dCTP in the reaction
mixture to increase the specific activity of the precursor pool. There
is a danger that the amount of the nucleotide could become limiting at
late stages in the amplification reaction.
2. If the thermal cycler
is not fitted with a heated lid, overlay the reaction mixtures with 1
drop (~50 µl) of light mineral oil. Alternatively, place a bead of wax
into the tube if using hot start PCR. Place the tubes or the microtiter
plate in the thermal cycler.
3. Amplify the nucleic acids using the denaturation, annealing, and polymerization times and temperatures listed in the table.
| Cycle Number | Denaturation Polymerization | Annealing | |
| 30 cycles | 30 sec at 95°C | 30 sec at 55°C | 1 min at 72°C |
| Last cycle | 1 min at 94°C | 30 sec at 55°C | 1 min at 72°C |
Times and temperatures may need to be adapted to suit the particular reaction conditions.
When using a reference template that differs from the target sequence in size:
4. Analyze and quantitate the amplified products.
(1)
Analyze the sizes of the amplified products in a 20- µl aliquot of each
of the reactions by gel electrophoresis and autoradiography.
(2) Excise the amplified bands of the control template and target sequences from the gel and measure the amount of radioactivity in each band in a liquid scintillation counter. Alternatively, scan the gel with the appropriate detector (e.g., GEHealthcare scanner or phosphorimager).
(3) Calculate the relative amounts of the two radiolabeled DNAs in each of the PCRs.
(4) Correct the amount of radioactivity to allow for differences in the molecular weights of the two radiolabeled DNAs
When using a reference template that contains a novel restriction site or lacks a naturally occurring site:
(1) Heat the samples to 94°C for 5 minutes following the final round of amplification.
(2) Allow the samples to cool gradually to room temperature and then digest a 20-µl aliquot of each of the reactions with the appropriate restriction enzyme
(3) Analyze the sizes of the amplified DNA fragments by gel electrophoresis and autoradiography or phosphorimaging.
(4) Excise the amplified bands of the control template and target sequences from the gel and measure the amount of radioactivity in each band in a liquid scintillation counter. Alternatively, scan the gel with the appropriate detector (e.g., GEHealthcare scanner or phosphorimager).
(5) Calculate the relative amounts of the two radiolabeled DNAs in each of the PCRs.
5. Correct the amount of radioactivity to allow for differences in the molecular weights of the two radiolabeled DNAs.
(1) Examine the results to determine the concentration of reference
template that yields approximately the same amount of amplified product
as the target sequence. Set up a second series of amplification
reactions (please see Step 4) containing a narrower range of
concentrations of reference template.
It is best to generate this series of dilutions from the appropriate tenfold dilution of the reference template (Step 2).
(2) Repeat Steps 5-7. For each
amplification reaction, measure the ratio of the yield of amplified
reference template to the yield of amplified target sequence. Plot this
ratio against the amount of reference template added to each
amplification reaction. From the resulting straight line, determine the
equivalence point (i.e., the amount of reference template that gives
exactly the same quantity of amplified product as the target sequence in
the reaction). Calculate the concentration of the target sequence in
the original sample.
1月5日,国家药监局发布医疗器械批准证明文件,其中罗氏诊断产品(苏州)有限公司最新获批一款全自动核酸提取及荧光PCR检测系统(国械注准20253222730)。这是目前罗氏诊断获批的首个国产PCR一体......
近日,海关总署物资装备采购中心发布多则公告,分别就“海关总署2025年数字化摄影X射线系统采购项目(重新招标)”“海关总署2025年PCR仪采购项目(重新招标)”“海关总署2025年彩色多普勒超声诊断......
医疗器械优先审批申请审核结果公示(2025年第14号)依据原国家食品药品监督管理总局《医疗器械优先审批程序》(总局公告2016年168号),对申请优先审批的医疗器械注册申请进行审核,现将符合优先审批情......
近日,海关总署陆续公布了一批分析仪器的采购项目中标结果,涵盖气相色谱仪、超高效液相色谱-三重四极杆质谱仪、波长色散X射线荧光光谱、PCR仪蛋白质测定仪、基因测序仪等多个领域,总中标金额高达6900余万......
全球生命科学研究和临床诊断产品领域的领导者伯乐实验室有限公司(纽约证券交易所代码:BIO和BIO.B)近日宣布推出四款新的微滴式数字PCR(ddPCR™)平台。新推出的仪器包括伯乐公司的QXConti......
国家药品监督管理局医疗器械技术审评中心发布医疗器械优先审批申请审核结果公示(2025年第6号),同意了苏州淦江生物技术有限公司申请的运动神经元存活基因1(SMN1)检测试剂盒(PCR-荧光探针熔解曲线......
近日,华中农业大学发布多个实验室仪器设备政府采购意向,采购的产品包括:超高分辨多色快速成像系统、荧光定量PCR仪、显微镜、蛋白纯化系统、分析天平、电泳仪、摇床、细胞破碎仪、核酸转染系统、纯水系统等,采......
Geneoscopy公司周三宣布已完成1.05亿美元的C轮融资。此轮融资由伯乐实验室领投,两家公司在一份联合声明中表示,这笔资金将用于支持Geneoscopy公司无创结直肠癌筛查检测的推出。参与此次融......
波兰生命科学公司ScopeFluidics近日表示,在收到交易的最后一笔款项后,该公司最近敲定了以1.3亿美元(约合9.5亿元人民币)的价格将其子公司CuriosityDiagnostics出售给Bi......
京药监发〔2024〕261号各区市场监管局,房山区燕山市场监管分局,市市场监管局机场分局,经开区商务金融局,市药监局各分局,各相关事业单位:为深入贯彻落实医疗器械生产监管相关法规要求,进一步规范北京市......